Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
APAM
|
Sarah A Johnson
Exec VP, CLO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 16,187 Added 18.44% |
-
|
Mar 01
2022 |
APAM
|
Gregory K Ramirez
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 16,187 Added 19.58% |
-
|
Mar 01
2022 |
APAM
|
Eileen Lee Kwei
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 17,986 Added 38.46% |
-
|
Mar 01
2022 |
AIN
|
Joseph M Gaug
VP-General Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 1,685 Added 78.45% |
-
|
Mar 01
2022 |
AIN
|
Joseph M Gaug
VP-General Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct | 1,685 Reduced 100.0% |
$144,388
$85.69 p/Share
|
Mar 01
2022 |
CCOI
|
Sheryl Lynn Kennedy |
SELL
Open market or private sale
|
Direct | 1,100 Reduced 22.45% |
$68,497
$62.27 p/Share
|
Mar 01
2022 |
IBTX
|
James C White
EVP, Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 1,361 Reduced 9.1% |
$101,830
$74.82 p/Share
|
Mar 01
2022 |
MATX
|
Peter T Heilmann
EVP, Chief Admin. Officer & GC |
SELL
Open market or private sale
|
Direct | 12,130 Reduced 22.6% |
$1,340,486
$110.51 p/Share
|
Mar 01
2022 |
MATX
|
Kuuhaku T Park
Senior Vice President |
SELL
Open market or private sale
|
Direct | 800 Reduced 6.76% |
$85,192
$106.49 p/Share
|
Mar 01
2022 |
MATX
|
Jason Lee Taylor
Senior Vice President |
SELL
Open market or private sale
|
Direct | 3,977 Reduced 46.0% |
$422,994
$106.36 p/Share
|
Mar 01
2022 |
CYTK
|
John T Henderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,166 Added 18.73% |
$22,746
$5.46 p/Share
|
Mar 01
2022 |
AQUA
|
Julia A Sloat
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,217 Added 50.0% |
-
|
Mar 01
2022 |
BL
|
Thomas Unterman
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,000 Added 2.15% |
$5,000
$5.0 p/Share
|
Mar 01
2022 |
BL
|
Thomas Unterman
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.1% |
$37,845
$75.69 p/Share
|
Mar 01
2022 |
BL
|
Thomas Unterman
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 34 Reduced 0.07% |
$2,573
$75.69 p/Share
|
Mar 01
2022 |
SRPT
|
Ryan Edward Brown
EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 184 Reduced 0.95% |
$13,809
$75.05 p/Share
|
Mar 01
2022 |
SRPT
|
Ian Michael Estepan
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 376 Reduced 1.41% |
$28,219
$75.05 p/Share
|
Mar 01
2022 |
SRPT
|
Louise Rodino Klapac
Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 572 Reduced 0.87% |
$42,929
$75.05 p/Share
|
Mar 01
2022 |
PFGC
|
Patrick T. Hagerty |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.33% |
$27,875
$55.75 p/Share
|
Mar 01
2022 |
RMO
|
Borgwarner Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,654,954 Reduced 12.2% |
$2,829,971
$1.71 p/Share
|
Mar 01
2022 |
UHS
|
Alan B Miller
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 590,000 Added 26.41% |
$85,201,902
$144.41 p/Share
|
Mar 01
2022 |
UHS
|
Alan B Miller
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 543,363 Reduced 33.05% |
$78,467,053
$144.41 p/Share
|
Mar 01
2022 |
GLPI
|
Barry F Schwartz |
BUY
Open market or private purchase
|
Direct | 7,500 Added 14.16% |
$339,375
$45.25 p/Share
|
Mar 01
2022 |
DOCU
|
Cain A Hayes
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 154 Added 16.63% |
-
|
Mar 01
2022 |
CSL
|
Robert M. Roche
VP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,503 Reduced 9.71% |
$579,820
$231.65 p/Share
|
Mar 01
2022 |
FDS
|
Frederick Philip Snow
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 27.82% |
$412,250
$164.9 p/Share
|
Mar 01
2022 |
FDS
|
Frederick Philip Snow
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 38.54% |
$1,015,175
$406.07 p/Share
|
Mar 01
2022 |
TDY
|
Charles Crocker
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 7.53% |
$258,920
$64.73 p/Share
|
Mar 01
2022 |
TDY
|
Charles Crocker
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 8.14% |
$1,712,000
$428.0 p/Share
|
Mar 01
2022 |
ZIMV
|
Zimmer Biomet Holdings, Inc.
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct | 20,918,542 Reduced 80.3% |
-
|
Mar 01
2022 |
CMI
|
Tracy A Embree
President - Distribution |
BUY
Grant, award, or other acquisition
|
Direct | 2,202 Added 11.06% |
-
|
Mar 01
2022 |
VRSK
|
Lee Shavel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 483 Reduced 1.15% |
$85,641
$177.31 p/Share
|
Mar 01
2022 |
ED
|
Timothy Cawley
Chairman, President & CEO |
BUY
Open market or private purchase
|
Direct | 80 Added 0.46% |
$6,887
$86.09 p/Share
|
Mar 01
2022 |
KMI
|
Jesse Arenivas
VP (President, CO2 and ETV) |
SELL
Open market or private sale
|
Direct | 65,000 Reduced 66.51% |
$1,135,550
$17.47 p/Share
|
Mar 01
2022 |
SRE
|
Peter R Wall
SVP, Controller and CAO |
SELL
Open market or private sale
|
Direct | 2,559 Reduced 27.41% |
$369,648
$144.45 p/Share
|
Mar 01
2022 |
SF
|
Victor Nesi
Co-President |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.52% |
$717,400
$71.74 p/Share
|
Mar 01
2022 |
RWAY
|
Ocm Growth Holdings LLC |
BUY
Open market or private purchase
|
Direct | 15,359 Added 0.07% |
$205,043
$13.35 p/Share
|
Mar 01
2022 |
INTU
|
Brad D Smith
Director |
SELL
Bona fide gift
|
Direct | 8,327 Reduced 2.04% |
-
|
Mar 01
2022 |
EVRI
|
Randy L Taylor
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 694 Added 0.32% |
-
|
Mar 01
2022 |
EVRI
|
Randy L Taylor
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 309 Reduced 0.14% |
$6,721
$21.75 p/Share
|
Mar 01
2022 |
MDC
|
Herbert T Buchwald
Director |
SELL
Other acquisition or disposition
|
Direct | 9,091 Reduced 100.0% |
-
|
Mar 01
2022 |
MDC
|
Herbert T Buchwald
Director |
BUY
Other acquisition or disposition
|
Indirect | 9,091 Added 47.72% |
-
|
Mar 01
2022 |
MDC
|
Paris G Reece Iii
Director |
SELL
Other acquisition or disposition
|
Direct | 9,091 Reduced 100.0% |
-
|
Mar 01
2022 |
MDC
|
Paris G Reece Iii
Director |
BUY
Other acquisition or disposition
|
Indirect | 9,091 Added 11.92% |
-
|
Mar 01
2022 |
MDC
|
David Siegel
Director |
SELL
Bona fide gift
|
Direct | 9,091 Reduced 100.0% |
-
|
Mar 01
2022 |
MDC
|
David Siegel
Director |
BUY
Bona fide gift
|
Indirect | 9,091 Added 28.31% |
-
|
Mar 01
2022 |
NILE
|
Milton C Ault Iii
Executive Chairman |
BUY
Open market or private purchase
|
Indirect | 39,069 Added 0.56% |
$37,897
$0.97 p/Share
|
Mar 01
2022 |
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 2,458 Added 0.05% |
$8,849
$3.6 p/Share
|
Mar 01
2022 |
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 2,458 Added 0.05% |
$8,849
$3.6 p/Share
|
Mar 01
2022 |
DRTT
|
Steven Parry
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 10.57% |
$9,850
$1.97 p/Share
|
Mar 01
2022 |